← Back to Search

Other

Effect of Different Ingestion Doses of Celastrol on Human Sperm Motility

N/A
Waitlist Available
Led By Rubin Patel, MD
Research Sponsored by Legend Labz, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one month
Awards & highlights
No Placebo-Only Group

Summary

This trial involves healthy men aged 18-40 taking increasing doses of celastrol to see how it affects their sperm count and movement. The study will measure changes in sperm over time.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one month
This trial's timeline: 3 weeks for screening, Varies for treatment, and one month for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Amount of Sperm in 1 mL of Ejaculate after Celastrol Ingestion
Motility of Sperm in 1 mL of Ejaculate after Celastrol Ingestion

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Amount of Celastrol AdministeredExperimental Treatment1 Intervention
Increasing doses of Celastrol to each of five male subjects

Find a Location

Who is running the clinical trial?

Legend Labz, Inc.Lead Sponsor
1 Previous Clinical Trials
35 Total Patients Enrolled
Rubin Patel, MDPrincipal InvestigatorLegend Labz, Inc.
1 Previous Clinical Trials
35 Total Patients Enrolled
~1 spots leftby Dec 2025